Finnifty
Nifty Bank
Nifty Next 50
Sensex
I
Integrated Hi-Tech
INTEGHIT Share Price
Information Technology3.13
-0.06 (-1.88%)
as on 29 Jul 2025 at 15:15
1D
BSE
Market Cap
₹3 Cr
PE Ratio
0.00
ROCE
-295.41%
Today Integrated Hi-Tech opened at 3.13 while its previous close was at 3.19. In todays trading session INTEGHIT reached a high of 3.19 and low of 3.13. The average traded price for today is 3.13. The 50 DMA stands at 704.34 and 200 DMA is at 598.73. Looking at intraday trend, the stock is in Downtrend.
Get 10+ Layouts, 100+ Indicators, Custom Timeframes & All Drawing Tools for FREE.
INTEGHIT Stock Performance
Markets Today
High
3.19
Low
3.13
Open at
3.13
Prev Close
3.19
Volumes
50,873
Avg Price
3.13
Lower Circuit
3.07
Upper Circuit
3.19
Last Traded Details
Quantity
1
Time
15:15:00
Price Movement
3.13
3.13
3.19
0.00%down sideup side1.88% 
Historical Performance
3 M High
6.30
3 M Low
2.66
1 Yr High
10.26
1 Yr Low
2.66
3 Yr High
14.82
3 Yr Low
2.66
5 Yr High
14.82
5 Yr Low
2.66
1-Year Performance
2.66
3.13
10.26
0.00%down sideup side1.88%
INTEGHIT Latest News
View All News
Laurus Labs Reports Strong Q1 Performance with 31% Revenue Growth, CDMO Business Drives Margins
Laurus Labs delivered robust quarterly results with revenues of INR 1,570 crores, marking 31% year-on-year growth. The CDMO business showed strong performance with sales of INR 493 crores, driven by mid-to-late stage NCE deliveries and increased Big Pharma projects. The company maintains over 110 active CDMO projects across Human Health, Animal Health, and Crop Sciences. Gross margins expanded to 59%, while EBITDA margins improved by 10.5 percentage points to approximately 25%. The Generics division grew 12% to INR 1,048 crores, supported by volume expansion in ARV and developed market sales. Laurus Bio reported flat sales of INR 29 crores due to customer-specific scale-up challenges. The company announced three major capacity expansions including microbial fermentation facility at Vizag, gene therapy and ADC facility at Shameerpet, and formulation facility under Krka joint venture. Management expects CDMO contribution to potentially reach 50% of revenue in the medium term, up from current 30%. The company invested INR 265 crores in capex and maintains net debt of INR 2,388 crores with debt-to-EBITDA ratio of 1.8.
8 hours ago
Laurus Labs Targets 25% EBITDA Margins, CDMO Business to Exceed 30% Revenue Share
Laurus Labs expects gross margins to remain in the 55-60% range for the financial year ending in March, driven by higher contribution from non-antiretroviral products and growing CDMO business. The company is targeting 25% EBITDA margins for the year, up from 20% last year. CEO Satyanarayana Chava expects CDMO revenue contribution to exceed 30% this year, with the business targeting ₹2,000 crore in CDMO revenue annually. The company supplied three new chemical entities for commercial supply in the last two quarters. Laurus Labs sees minimal impact from the US biotech funding slowdown as most revenue comes from big pharma companies with strong pipelines rather than small biotech firms. The majority of CDMO revenues are from late-phase or commercial stage molecules rather than early-stage development.
1 day ago
Laurus Labs Sets Financial Targets with Gross Margins at 55-60% and CDMO Revenue Growth Plans
Laurus Labs has outlined its financial expectations, targeting gross margins to remain between 55-60%. The company plans to maintain net debt at no more than 50% of annual revenue and keep its debt/EBITDA ratio at 2-2.5x. Laurus Labs expects ARV revenue of approximately Rs 2,500 crore with a margin of Rs 200 crore. The pharmaceutical company anticipates its CDMO (Contract Development and Manufacturing Organization) contribution to increase from the current 30% to around 50% of total revenue in the medium term.
1 day ago
INTEGHIT Share Price History
View Price HistoryClose Price
Volume
INTEGHIT share price in last 10 trading sessions
| Day | Open | Close | Change% | Day High | Day Low | Volume |
|---|---|---|---|---|---|---|
| 28 Jul 2025 | 833.00 | 889.25 | 6.75% | 901.50 | 828.05 | 1,76,17,498 |
| 25 Jul 2025 | 839.10 | 837.75 | -0.16% | 846.00 | 825.05 | 52,68,018 |
| 24 Jul 2025 | 823.95 | 836.50 | 1.52% | 842.00 | 817.15 | 23,58,313 |
| 23 Jul 2025 | 825.00 | 822.50 | -0.30% | 825.90 | 817.05 | 11,56,632 |
| 22 Jul 2025 | 831.90 | 823.35 | -1.03% | 832.00 | 815.00 | 9,47,754 |
| 21 Jul 2025 | 827.20 | 829.45 | 0.27% | 833.90 | 824.15 | 12,16,659 |
| 18 Jul 2025 | 825.10 | 827.00 | 0.23% | 829.00 | 814.50 | 9,89,477 |
| 17 Jul 2025 | 825.90 | 821.50 | -0.53% | 830.00 | 815.20 | 15,18,302 |
| 15 Jul 2025 | 825.75 | 827.05 | 0.16% | 834.35 | 820.45 | 20,80,040 |
| 14 Jul 2025 | 788.20 | 823.85 | 4.52% | 827.50 | 788.20 | 50,83,453 |
INTEGHIT Fundamentals
View FundamentalsCompany Valuation
Market Cap (₹ Cr.)
3
PE Ratio
-
PB Ratio
-7.50
Dividend Yield
-
ROE
-295.41%
ROCE
-295.41%
Book Value (₹)
-0.43
Face Value (₹)
10.00
Share Holding Pattern
| Held By | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Promoters | 11.05% | 11.05% | 11.05% | 11.05% | 11.05% |
| Domestic Institutional Investors (DII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Foreign Institutional Investors (FII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Investors | 70.93% | 70.95% | 70.92% | 71.60% | 72.98% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
INTEGHIT Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
INTEGHIT Technicals
View TechnicalsMoving Averages
| Period | Simple | Signal |
|---|---|---|
| 5-SMA | 841.87 | Bullish |
| 10-SMA | 833.82 | Bullish |
| 20-SMA | 801.65 | Bullish |
| 50-SMA | 704.34 | Bullish |
| 100-SMA | 651.96 | Bullish |
| 200-SMA | 598.73 | Bullish |
Technical Indicators
| Indicator | Value | Action |
|---|---|---|
| RSI(14) | 87.87 | Overbought |
| ATR(14) | 21.97 | Volatile |
| STOCH(9,6) | 85.52 | Overbought |
| STOCH RSI(14) | 56.25 | Neutral |
| MACD(12,26) | 1.88 | Bullish |
| ADX(14) | 60.42 | Very Strong Trend |
Summary of Technical Indicators for INTEGHIT
INTEGHIT Financials Summary
View By:
Revenue
EBITDA
Net Profit
EPS
Revenue
In Crores
INTEGHIT Financials
View By:
Income Statement
In Crores
Yearly
Quarterly
Balance Sheet
In Crores
Cash Flow
In Crores
Past Corporate Actions
| Date | Corporate Action | Information |
|---|---|---|
| 09 Jul 2025 | Quarterly Result Announcement | NA |
| 15 May 2025 | Annual General Meeting | NA |
| 24 Apr 2025 | Dividend | ₹ 0.80 /share |
| 10 Apr 2025 | Quarterly Result Announcement | NA |
| 06 Jan 2025 | Quarterly Result Announcement | NA |
Quarterly Result Announcement
Annual General Meeting
Dividend
Get In-depth View of INTEGHIT Quaterly Results, Balance Sheet, Cashflows & Corporate Action.
INTEGHIT Revenue Growth
All values are in Crores
Revenue
Profit
Loss
| Financial Year | Revenue | Revenue Growth | Net Profit | Profit Growth |
|---|---|---|---|---|
| FY 2023-24 | 0 | -37.83% | -3 | -3839.52% |
| FY 2022-23 | 0 | -20.77% | -8 | -73.58% |
| FY 2021-22 | 0 | -76.68% | -0 | -102.89% |
Top Mutual Funds Invested in INTEGHIT
Name | NAV | AUM (Cr.) | Weightage | 1Y Return | 3Y Returns | 5Y Returns  | Expense Ratio |
|---|---|---|---|---|---|---|---|
 Sundaram Small Cap Fund Direct - Growth | ₹ 287.43 | ₹ 3,438.89 | 0.95% | 2.64% | 24.18% | 32.28% | 0.86% |
 Motilal Oswal Nifty Smallcap 250 Index Fund Direct - Growth | ₹ 38.70 | ₹ 978.30 | 1.35% | -2.57% | 25.79% | 31.73% | 0.33% |
 Axis Small Cap Fund Direct - Growth | ₹ 123.58 | ₹ 26,379.20 | 0.41% | 4.34% | 22.81% | 31.09% | 0.56% |
 SBI Mid Cap Fund Direct - Growth | ₹ 259.53 | ₹ 23,269.00 | 0.00% | -1.44% | 19.15% | 28.50% | 0.85% |
 Mahindra Manulife Multi Cap Fund Direct - Growth | ₹ 41.46 | ₹ 5,761.84 | 1.97% | 1.49% | 23.88% | 28.09% | 0.40% |
 Franklin India Mid Cap Fund Direct - Growth | ₹ 3,099.91 | ₹ 12,784.80 | 0.93% | 2.41% | 25.35% | 27.25% | 0.94% |
SBI Large & Midcap Fund Direct - Growth | ₹ 671.03 | ₹ 33,031.10 | 1.08% | 6.06% | 21.20% | 25.72% | 0.73% |
Mahindra Manulife Large & Mid Cap Fund Direct - Growth | ₹ 29.82 | ₹ 2,765.30 | 1.75% | -1.39% | 19.78% | 25.35% | 0.45% |
SBI Healthcare Opportunities Fund Direct - Growth | ₹ 503.87 | ₹ 3,849.24 | 2.71% | 19.68% | 29.99% | 25.18% | 0.89% |
 DSP ELSS Tax Saver Fund Direct - Growth | ₹ 154.43 | ₹ 17,427.60 | 0.87% | 1.06% | 21.73% | 25.02% | 0.68% |
Sundaram Small Cap Fund Direct - Growth
1Y Returns
2.64 %
3Y Returns
24.18 %
5Y Returns
32.28 %
Motilal Oswal Nifty Smallcap 250 Index Fund Direct - Growth
1Y Returns
-2.57 %
3Y Returns
25.79 %
5Y Returns
31.73 %
Axis Small Cap Fund Direct - Growth
1Y Returns
4.34 %
3Y Returns
22.81 %
5Y Returns
31.09 %
SBI Mid Cap Fund Direct - Growth
1Y Returns
-1.44 %
3Y Returns
19.15 %
5Y Returns
28.50 %
Mahindra Manulife Multi Cap Fund Direct - Growth
1Y Returns
1.49 %
3Y Returns
23.88 %
5Y Returns
28.09 %
Franklin India Mid Cap Fund Direct - Growth
1Y Returns
2.41 %
3Y Returns
25.35 %
5Y Returns
27.25 %
SBI Large & Midcap Fund Direct - Growth
1Y Returns
6.06 %
3Y Returns
21.20 %
5Y Returns
25.72 %
Mahindra Manulife Large & Mid Cap Fund Direct - Growth
1Y Returns
-1.39 %
3Y Returns
19.78 %
5Y Returns
25.35 %
SBI Healthcare Opportunities Fund Direct - Growth
1Y Returns
19.68 %
3Y Returns
29.99 %
5Y Returns
25.18 %
DSP ELSS Tax Saver Fund Direct - Growth
1Y Returns
1.06 %
3Y Returns
21.73 %
5Y Returns
25.02 %
INTEGHIT Similar Stocks
View All
Top Gainers Today
View All GainersR
Reliance Industries
1,417.10
(2.13%)
H
HDFC Bank
2,021.60
(0.65%)
T
Tata Consultancy Services
3,056.00
(-0.76%)
B
Bharti Airtel
1,918.30
(1.48%)
S
State Bank of India
799.20
(0.26%)
I
Infosys
1,513.70
(-0.15%)
H
Hindustan Unilever
2,453.60
(0.49%)
B
Bajaj Finance
886.55
(0.69%)
I
ITC
408.45
(-0.35%)
L
Larsen & Toubro
3,495.60
(2.14%)
S
Sun Pharmaceutical
1,710.50
(0.49%)
M
Mahindra & Mahindra
3,199.40
(-0.32%)
H
HCL Technologies
1,472.40
(0.43%)
K
Kotak Bank
1,972.70
(0.31%)
M
Maruti Suzuki
12,469.00
(1.05%)
U
UltraTech Cement
12,221.00
(-0.16%)
A
Axis Bank
1,064.20
(-0.88%)
N
NTPC
334.60
(0.50%)
B
Bajaj Finserv
1,972.60
(-0.26%)
O
Oil & Natural Gas Corporation
241.44
(0.59%)
T
Titan
3,379.20
(-0.41%)
A
Adani Ports & SEZ
1,395.90
(1.45%)
E
Eternal
306.55
(-0.24%)
A
Adani Enterprises
2,547.90
(1.01%)
B
Bharat Electronics
388.25
(-0.26%)
P
Power Grid Corporation of India
293.10
(0.41%)
W
Wipro
251.80
(0.70%)
J
JSW Steel
1,034.90
(0.59%)
T
Tata Motors
692.35
(1.38%)
C
Coal India
383.65
(1.40%)
A
Asian Paints
2,401.50
(1.78%)
B
Bajaj Auto
8,127.50
(0.47%)
N
Nestle
2,223.70
(-0.25%)
T
Tata Steel
161.69
(1.26%)
J
Jio Financial Services
321.10
(4.47%)
G
Grasim Industries
2,743.00
(0.58%)
S
SBI Life Insurance
1,833.40
(-0.92%)
T
Trent
5,001.50
(0.15%)
H
HDFC Life Insurance
756.35
(-0.64%)
H
Hindalco Industries
692.70
(0.49%)
E
Eicher Motors
5,470.50
(1.57%)
T
Tech Mahindra
1,453.80
(0.22%)
C
Cipla
1,574.00
(0.13%)
S
Shriram Finance
638.35
(0.77%)
D
Dr Reddys Laboratories
1,299.80
(0.96%)
A
Apollo Hospitals
7,456.00
(1.35%)
T
Tata Consumer Products
1,061.60
(0.16%)
H
Hero Motocorp
4,325.20
(0.79%)
I
Indusind Bank
808.20
(0.77%)
Top Losers Today
View All LosersR
Reliance Industries
1,417.10
(2.13%)
H
HDFC Bank
2,021.60
(0.65%)
T
Tata Consultancy Services
3,056.00
(-0.76%)
B
Bharti Airtel
1,918.30
(1.48%)
S
State Bank of India
799.20
(0.26%)
I
Infosys
1,513.70
(-0.15%)
H
Hindustan Unilever
2,453.60
(0.49%)
B
Bajaj Finance
886.55
(0.69%)
I
ITC
408.45
(-0.35%)
L
Larsen & Toubro
3,495.60
(2.14%)
S
Sun Pharmaceutical
1,710.50
(0.49%)
M
Mahindra & Mahindra
3,199.40
(-0.32%)
H
HCL Technologies
1,472.40
(0.43%)
K
Kotak Bank
1,972.70
(0.31%)
M
Maruti Suzuki
12,469.00
(1.05%)
U
UltraTech Cement
12,221.00
(-0.16%)
A
Axis Bank
1,064.20
(-0.88%)
N
NTPC
334.60
(0.50%)
B
Bajaj Finserv
1,972.60
(-0.26%)
O
Oil & Natural Gas Corporation
241.44
(0.59%)
T
Titan
3,379.20
(-0.41%)
A
Adani Ports & SEZ
1,395.90
(1.45%)
E
Eternal
306.55
(-0.24%)
A
Adani Enterprises
2,547.90
(1.01%)
B
Bharat Electronics
388.25
(-0.26%)
P
Power Grid Corporation of India
293.10
(0.41%)
W
Wipro
251.80
(0.70%)
J
JSW Steel
1,034.90
(0.59%)
T
Tata Motors
692.35
(1.38%)
C
Coal India
383.65
(1.40%)
A
Asian Paints
2,401.50
(1.78%)
B
Bajaj Auto
8,127.50
(0.47%)
N
Nestle
2,223.70
(-0.25%)
T
Tata Steel
161.69
(1.26%)
J
Jio Financial Services
321.10
(4.47%)
G
Grasim Industries
2,743.00
(0.58%)
S
SBI Life Insurance
1,833.40
(-0.92%)
T
Trent
5,001.50
(0.15%)
H
HDFC Life Insurance
756.35
(-0.64%)
H
Hindalco Industries
692.70
(0.49%)
E
Eicher Motors
5,470.50
(1.57%)
T
Tech Mahindra
1,453.80
(0.22%)
C
Cipla
1,574.00
(0.13%)
S
Shriram Finance
638.35
(0.77%)
D
Dr Reddys Laboratories
1,299.80
(0.96%)
A
Apollo Hospitals
7,456.00
(1.35%)
T
Tata Consumer Products
1,061.60
(0.16%)
H
Hero Motocorp
4,325.20
(0.79%)
I
Indusind Bank
808.20
(0.77%)
NSE Indices Today
All NSE Indices
R
Reliance Industries
1,417.10
(2.13%)
H
HDFC Bank
2,021.60
(0.65%)
T
Tata Consultancy Services
3,056.00
(-0.76%)
B
Bharti Airtel
1,918.30
(1.48%)
S
State Bank of India
799.20
(0.26%)
I
Infosys
1,513.70
(-0.15%)
H
Hindustan Unilever
2,453.60
(0.49%)
B
Bajaj Finance
886.55
(0.69%)
I
ITC
408.45
(-0.35%)
L
Larsen & Toubro
3,495.60
(2.14%)
S
Sun Pharmaceutical
1,710.50
(0.49%)
M
Mahindra & Mahindra
3,199.40
(-0.32%)
H
HCL Technologies
1,472.40
(0.43%)
K
Kotak Bank
1,972.70
(0.31%)
M
Maruti Suzuki
12,469.00
(1.05%)
U
UltraTech Cement
12,221.00
(-0.16%)
A
Axis Bank
1,064.20
(-0.88%)
N
NTPC
334.60
(0.50%)
B
Bajaj Finserv
1,972.60
(-0.26%)
O
Oil & Natural Gas Corporation
241.44
(0.59%)
T
Titan
3,379.20
(-0.41%)
A
Adani Ports & SEZ
1,395.90
(1.45%)
E
Eternal
306.55
(-0.24%)
A
Adani Enterprises
2,547.90
(1.01%)
B
Bharat Electronics
388.25
(-0.26%)
P
Power Grid Corporation of India
293.10
(0.41%)
W
Wipro
251.80
(0.70%)
J
JSW Steel
1,034.90
(0.59%)
T
Tata Motors
692.35
(1.38%)
C
Coal India
383.65
(1.40%)
A
Asian Paints
2,401.50
(1.78%)
B
Bajaj Auto
8,127.50
(0.47%)
N
Nestle
2,223.70
(-0.25%)
T
Tata Steel
161.69
(1.26%)
J
Jio Financial Services
321.10
(4.47%)
G
Grasim Industries
2,743.00
(0.58%)
S
SBI Life Insurance
1,833.40
(-0.92%)
T
Trent
5,001.50
(0.15%)
H
HDFC Life Insurance
756.35
(-0.64%)
H
Hindalco Industries
692.70
(0.49%)
E
Eicher Motors
5,470.50
(1.57%)
T
Tech Mahindra
1,453.80
(0.22%)
C
Cipla
1,574.00
(0.13%)
S
Shriram Finance
638.35
(0.77%)
D
Dr Reddys Laboratories
1,299.80
(0.96%)
A
Apollo Hospitals
7,456.00
(1.35%)
T
Tata Consumer Products
1,061.60
(0.16%)
H
Hero Motocorp
4,325.20
(0.79%)
I
Indusind Bank
808.20
(0.77%)
BSE Indices Today
All BSE Indices
R
Reliance Industries
1,417.10
(2.13%)
H
HDFC Bank
2,021.60
(0.65%)
T
Tata Consultancy Services
3,056.00
(-0.76%)
B
Bharti Airtel
1,918.30
(1.48%)
S
State Bank of India
799.20
(0.26%)
I
Infosys
1,513.70
(-0.15%)
H
Hindustan Unilever
2,453.60
(0.49%)
B
Bajaj Finance
886.55
(0.69%)
I
ITC
408.45
(-0.35%)
L
Larsen & Toubro
3,495.60
(2.14%)
S
Sun Pharmaceutical
1,710.50
(0.49%)
M
Mahindra & Mahindra
3,199.40
(-0.32%)
H
HCL Technologies
1,472.40
(0.43%)
K
Kotak Bank
1,972.70
(0.31%)
M
Maruti Suzuki
12,469.00
(1.05%)
U
UltraTech Cement
12,221.00
(-0.16%)
A
Axis Bank
1,064.20
(-0.88%)
N
NTPC
334.60
(0.50%)
B
Bajaj Finserv
1,972.60
(-0.26%)
O
Oil & Natural Gas Corporation
241.44
(0.59%)
T
Titan
3,379.20
(-0.41%)
A
Adani Ports & SEZ
1,395.90
(1.45%)
E
Eternal
306.55
(-0.24%)
A
Adani Enterprises
2,547.90
(1.01%)
B
Bharat Electronics
388.25
(-0.26%)
P
Power Grid Corporation of India
293.10
(0.41%)
W
Wipro
251.80
(0.70%)
J
JSW Steel
1,034.90
(0.59%)
T
Tata Motors
692.35
(1.38%)
C
Coal India
383.65
(1.40%)
A
Asian Paints
2,401.50
(1.78%)
B
Bajaj Auto
8,127.50
(0.47%)
N
Nestle
2,223.70
(-0.25%)
T
Tata Steel
161.69
(1.26%)
J
Jio Financial Services
321.10
(4.47%)
G
Grasim Industries
2,743.00
(0.58%)
S
SBI Life Insurance
1,833.40
(-0.92%)
T
Trent
5,001.50
(0.15%)
H
HDFC Life Insurance
756.35
(-0.64%)
H
Hindalco Industries
692.70
(0.49%)
E
Eicher Motors
5,470.50
(1.57%)
T
Tech Mahindra
1,453.80
(0.22%)
C
Cipla
1,574.00
(0.13%)
S
Shriram Finance
638.35
(0.77%)
D
Dr Reddys Laboratories
1,299.80
(0.96%)
A
Apollo Hospitals
7,456.00
(1.35%)
T
Tata Consumer Products
1,061.60
(0.16%)
H
Hero Motocorp
4,325.20
(0.79%)
I
Indusind Bank
808.20
(0.77%)
Open IPOs
View All
Stock Calculators
View All
What’s New In The Market
L
Laurus Labs Reports Strong Q1 Performance with 31% Revenue Growth, CDMO Business Drives Margins
Laurus Labs delivered robust quarterly results with revenues of INR 1,570 crores, marking 31% year-on-year growth. The CDMO business showed strong performance with sales of INR 493 crores, driven by mid-to-late stage NCE deliveries and increased Big Pharma projects. The company maintains over 110 active CDMO projects across Human Health, Animal Health, and Crop Sciences. Gross margins expanded to 59%, while EBITDA margins improved by 10.5 percentage points to approximately 25%. The Generics division grew 12% to INR 1,048 crores, supported by volume expansion in ARV and developed market sales. Laurus Bio reported flat sales of INR 29 crores due to customer-specific scale-up challenges. The company announced three major capacity expansions including microbial fermentation facility at Vizag, gene therapy and ADC facility at Shameerpet, and formulation facility under Krka joint venture. Management expects CDMO contribution to potentially reach 50% of revenue in the medium term, up from current 30%. The company invested INR 265 crores in capex and maintains net debt of INR 2,388 crores with debt-to-EBITDA ratio of 1.8.
LAURUSLABS
909.85
20.60
(2.32%)
8 hours ago
L
Laurus Labs Targets 25% EBITDA Margins, CDMO Business to Exceed 30% Revenue Share
Laurus Labs expects gross margins to remain in the 55-60% range for the financial year ending in March, driven by higher contribution from non-antiretroviral products and growing CDMO business. The company is targeting 25% EBITDA margins for the year, up from 20% last year. CEO Satyanarayana Chava expects CDMO revenue contribution to exceed 30% this year, with the business targeting ₹2,000 crore in CDMO revenue annually. The company supplied three new chemical entities for commercial supply in the last two quarters. Laurus Labs sees minimal impact from the US biotech funding slowdown as most revenue comes from big pharma companies with strong pipelines rather than small biotech firms. The majority of CDMO revenues are from late-phase or commercial stage molecules rather than early-stage development.
LAURUSLABS
909.85
20.60
(2.32%)
1 day ago
L
Laurus Labs Sets Financial Targets with Gross Margins at 55-60% and CDMO Revenue Growth Plans
Laurus Labs has outlined its financial expectations, targeting gross margins to remain between 55-60%. The company plans to maintain net debt at no more than 50% of annual revenue and keep its debt/EBITDA ratio at 2-2.5x. Laurus Labs expects ARV revenue of approximately Rs 2,500 crore with a margin of Rs 200 crore. The pharmaceutical company anticipates its CDMO (Contract Development and Manufacturing Organization) contribution to increase from the current 30% to around 50% of total revenue in the medium term.
LAURUSLABS
909.85
20.60
(2.32%)
1 day ago
FAQs
What is the share price of Integrated Hi-Tech?
Integrated Hi-Tech share price as of today is ₹ 3.13 as on 29 Jul 2025 at 15:15.
What is the 52W high and 52W low of Integrated Hi-Tech?
The 52W high of Integrated Hi-Tech is ₹ 10.26 and 52W low is ₹ 2.66 as of 29 Jul 2025 at 15:15.
What is the return on Integrated Hi-Tech share?
The past returns of Integrated Hi-Tech share are -
- Past 1 year: -53.77%
- Past 3 years: -56.47%
- Past 5 years: -56.47%
What is the PE and PB Ratio of Integrated Hi-Tech?
The PE and PB ratio of Integrated Hi-Tech stands at 0.00 and -7.50 respectively as on 29 Jul 2025 at 15:15.
What is the EPS of Integrated Hi-Tech?
The EPS of Integrated Hi-Tech is -2.84 for the quarter ended Mar 2025 and -3.03 for the financial year 2024-25.
What is the shareholding pattern of Integrated Hi-Tech?
The shareholding pattern of Integrated Hi-Tech is as follows:
- DIIs - 0.00%
- FII - 0.00%
- Promoters - 11.05%
- Public Investors 72.98%
- Goverenment - 0.00%
How to buy Integrated Hi-Tech shares online?
Yes, you can buy shares of Integrated Hi-Tech online by opening Demat account with Dhan.
How to buy Integrated Hi-Tech shares on Dhan?
If you are a Dhan user already, you can buy Integrated Hi-Tech stocks from Dhan Trading App or Web Trading Platform. If you are new to Dhan follow the below steps:
- Download the Dhan App to Open a Demat Account
- Navigate to the “Money Tab”
- Add money to your account
- Search for Integrated Hi-Tech share
- Tap on “Buy”
How to buy Integrated Hi-Tech shares after market is closed?
You can easily buy the shares of Integrated Hi-Tech even after the markets are closed using the After Market Order feature on Dhan Trading App.
Invest in INTEGHIT
Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
error
Or Scan the QR Code to download the Dhan App
Dhan App
Chrome
Join us on
Follow us on
Partner with us
built with love
for Indians who love to invest & trade
We are part of Raise Financial Services
Explore | Sitemap
*All securities mentioned on this website are exemplary and not recommendatory.
*Current prices on the website are delayed by 15 mins, login to check live prices.
We are bullish on India, we are bullish on India's prospects to be one of the largest economies in the world. We believe that the stock market provides a unique opportunity for all of India's traders and investors to participate in the growth story of the country.
Yet, most investing & trading platforms in India have remained more or less the same over the past decade. Times have changed and retail traders and investors have become smarter about managing their trades and money. Modern traders & investors require an online trading platform that helps them keep up with the technological advancements of our time.
That's why we're building Dhan - to help you trade, to help you invest, and to help you participate in India's growth stock via the stock market with awesome features and an incredible experience.
©2021-2025 Raise Securities Private Limited (formerly Moneylicious Securities Private Limited). All rights reserved. CIN: U74999MH2012PTC433549 Raise Securities is part of Raise Financial Services.
SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016
Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320
Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai – 400104
Corporate Office: 302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai - 400066, Maharashtra, India. Customer Care: 9987761000.
For any query / feedback / clarifications, email at help@dhan.co.
Important Links: SEBI | BSE | NSE | MCX | CDSL | SCORES | ODR Portal | Investor Charter for Stock Brokers | Investor Charter for DP | UCC Advisory | e-Voting for Shareholders | NCL Client Collateral details |
MCXCCL Client Collateral details
Important Information: Terms of Usage | Disclaimers | Privacy Policy | Grievances | Risk Management Policy | Risk Disclosure | Advertisement Disclaimer | Referral Terms & Conditions | Saarthi 2.0 Mobile App for Investors
Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320
Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai – 400104
Corporate Office: 302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai - 400066, Maharashtra, India. Customer Care: 9987761000.
Details of client bank account
For any query / feedback / clarifications, email at help@dhan.co.
In case of grievances for any of the services rendered by Raise Securities Private Limited, please write to grievance@dhan.co (for NSE, BSE and MCX) or grievancedp@dhan.co (for Depository Participant). Please ensure that you carefully read the Risk Disclosure Document as prescribed by SEBI, our Terms of Use and Privacy Policy. Compliance Officer: Mr. Manish Garg and Mobile: 8655740961 Email: complianceofficer@dhan.co To lodge your complaints using SEBI SCORES, click here.
Disclaimer: All communications with the client via chat, phone, or email are for support purposes only. Any commitments or statements made by the agent (human or virtual) shall not be binding on the company.
DHAN is a brand owned by Raise Securities Private Limited. All DHAN clients are registered under Raise Securities Private Limited. Clients are advised to refer to our company as Raise Securities Private Limited when communicating with regulatory authorities.
Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances
Disclaimer: Investment in the securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit
Attention investors:
- Stock brokers can accept securities as margins from clients only by way of pledge in the depository system w.e.f September 01, 2020.
- Update your e-mail and phone number with your stock broker / depository participant and receive OTP directly from depository on your e-mail and/or mobile number to create pledge.
- Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.
Note: As a policy we do not give stock tips or recommendations and have not authorized anyone to give this on behalf of us. If you know anyone claiming to be a part of Dhan / / Raise or our associate companies or partners and offering such services, please report us on help@dhan.co. Important Information for Investors: To prevent unauthorized transactions in your trading / demat account, do not share your account details, credentials or any personal details with anyone. Keep your mobile number updated with your Stock Broker, Depository Participant and ensure that the same is registered with Stock Exchanges, Depository and KRAs. You will receive alerts and information on your registered mobile number / email for debit and other important transactions in your demat account directly from CDSL / Exchange on the same day. KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Stock Broker, DP, Mutual Fund, etc.), you need not undergo the same process again when you approach another intermediary. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. This is issued in the interest of investors.
Raise Securities Private Limited also known as Dhan is only an order collection platform that collects orders on behalf of clients and places them on BSE StarMF for execution. Client expressly agrees that Dhan is not liable or responsible and does not represent or warrant any damages regarding non- execution of orders or any incorrect execution of orders with regard to the funds chosen by the client or due to, but not being limited to, any link/system failure, delay in transfer of the funds on account of any unforeseen circumstances/issues in the banking system/payment aggregators or any other problems that may result in a delay in crediting the funds into the BSE Star MF's bank account.
Mutual fund investments are subject to market risks, read all scheme related documents carefully before investing. Dhan is not a distributor or agent of any mutual fund. Mutual Funds are not exchange-traded products. Any related disputes will not have access to the Exchange-investor redressal forum or arbitration mechanism. For other disclaimers please refer https://dhan.co/advertisement-disclaimer/
Download client registration documents (Rights & Obligations, Risk Disclosure Document, Do's & Don'ts) in vernacular language: BSE | NSE | MCX
Kindly, read the Advisory Guidelines of BSE | NSE | MCX for investors as prescribed by the exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client's assets
Important Links: SEBI | BSE | NSE | MCX | CDSL | SCORES | ODR Portal | Investor Charter for Stock Brokers | Investor Charter for DP | UCC Advisory | e-Voting for Shareholders | NCL Client Collateral details |
MCXCCL Client Collateral details
Important Information: Terms of Usage | Disclaimers | Privacy Policy | Grievances | Risk Management Policy | Risk Disclosure | Advertisement Disclaimer | Referral Terms & Conditions | Saarthi 2.0 Mobile App for Investors